drug

gemcitabine intravesical

1 story · latest Nov 6, 2026

Follow gemcitabine intravesical. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Sep 2025 · NDA219683
Brand: Inlexzo

Relationships

Developed by Johnson & Johnson

Timeline

FDA approves Janssen's gemcitabine system for bladder cancer

Nov 6Regulatory decisiongemcitabine Johnson & Johnson

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.